Skip to main content

Medical Research Future Fund (MRFF)

National funding to support inspiring medical and health research
Find key dates and links to MRFF funding schemes, as well as contact details of our specialist staff who can help you with the funding process.

The Medical Research Future Fund (MRFF) is a $20 billion investment in the health of Australians. Funds support researchers to make the next big medical discoveries that will benefit all Australians. It represents the single largest boost to research funding in Australia’s history.

MRFF strategies are complementary but separate to those addressed by the National Health and Medical Research Council (NHMRC) and are intended to complement other investments by state and territory governments, as well as the private sector.

Following a national consultation process involving community and sector participation, the Australian Medical Research Advisory Board (AMRAB), in conjunction with the federal government, released the 2018-2020 Medical Research Future Fund (MRFF) priorities, which will guide and inform future government decisions.

MRFF strategic platforms

The MRFF plans to transform health and medical research through 6 strategic platforms:

  1. Strategic and International Horizons: support stronger partnerships between researchers, healthcare professionals, governments and the community. This will help position Australia as a leader in significant global research, such as tackling antimicrobial resistance.
  2. Data and Infrastructure: make better use of existing data and infrastructure to help improve our health and medical research.
  3. Health Services and Systems: strengthen our health services and systems research to make healthcare more efficient and affordable.
  4. Capacity and Collaboration: develop the skills of researchers and healthcare professionals and encourage collaboration across health and medical research disciplines and sectors.
  5. Trials and Translation: support new and existing clinical trial networks to guide the development of new drugs and devices, new models of care, and improved clinical practice.
  6. Commercialisation: Support researchers to find a commercial partner or investor to help turn their discoveries into every day realities.

Some funding disbursements are expected to be made through competitive grants processes and targeted calls administered by the Department of Health, NHMRC, or other independent bodies.

Current funding opportunities

Investigator Grants: Medical Research Future Fund Priority Round
Applications open: 2 October 2019
Minimum data: TBC
Applications close: 27 November 2019
Contact: Nicole Richardson

BioMedTech Horizons Round 3 (BMTH 3.0)
EOI Applications open: 15 October 2019
Minimum data deadline: N/A
EOI Applications close: 16 December 2019
Contact: Duncan MacInnis or Ed Hendriks

Frontier in Medical and Health Research (stage 1 round 2)- FORECAST OPPORTUNITY- Expression of Interest
Applications open: TBC
Minimum data deadline: N/A
Applications close: TBC
Contact: Ed Hendriks
Guidelines from stage 1 round 1 are indicative of what this MRFF scheme is all about and are likely to be similar for this FORECAST opportunity.
If you are interested in applying please complete this Expression of Interest as soon as possible and submit it via the Research Services Portal - Notice of Intent (MRFF - Frontiers in Health and Medical Research Program).

International Clinical Trial Collaborations Program

2019 – Peer Review Cycle 3
Minimum data deadline: 20 November 2019
Applications close: 4 December 2019
Contact: Sherridan Blackman

For strategic writing advice, contact Ed Hendriks, MRFF Development Manager.